JP2022528271A5 - - Google Patents

Info

Publication number
JP2022528271A5
JP2022528271A5 JP2021560304A JP2021560304A JP2022528271A5 JP 2022528271 A5 JP2022528271 A5 JP 2022528271A5 JP 2021560304 A JP2021560304 A JP 2021560304A JP 2021560304 A JP2021560304 A JP 2021560304A JP 2022528271 A5 JP2022528271 A5 JP 2022528271A5
Authority
JP
Japan
Prior art keywords
benzoic acid
groups
dimethylsulfamoyl
substituted
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021560304A
Other languages
English (en)
Japanese (ja)
Other versions
JP7676317B2 (ja
JP2022528271A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/053158 external-priority patent/WO2020202072A1/en
Publication of JP2022528271A publication Critical patent/JP2022528271A/ja
Publication of JP2022528271A5 publication Critical patent/JP2022528271A5/ja
Application granted granted Critical
Publication of JP7676317B2 publication Critical patent/JP7676317B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021560304A 2019-04-02 2020-04-02 細胞内塩素イオン濃度のモジュレーター Active JP7676317B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102019000004929 2019-04-02
IT201900004929 2019-04-02
PCT/IB2020/053158 WO2020202072A1 (en) 2019-04-02 2020-04-02 Modulators of intracellular chloride concentration

Publications (3)

Publication Number Publication Date
JP2022528271A JP2022528271A (ja) 2022-06-09
JP2022528271A5 true JP2022528271A5 (enExample) 2023-04-10
JP7676317B2 JP7676317B2 (ja) 2025-05-14

Family

ID=67185615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021560304A Active JP7676317B2 (ja) 2019-04-02 2020-04-02 細胞内塩素イオン濃度のモジュレーター

Country Status (10)

Country Link
US (1) US20220184008A1 (enExample)
EP (1) EP3947345A1 (enExample)
JP (1) JP7676317B2 (enExample)
KR (1) KR20220022051A (enExample)
CN (2) CN114174259A (enExample)
AU (1) AU2020251023B2 (enExample)
CA (1) CA3135339A1 (enExample)
IL (1) IL286900B2 (enExample)
SG (1) SG11202110950XA (enExample)
WO (1) WO2020202072A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202300007521A1 (it) * 2023-04-18 2024-10-18 Iama Therapeutics S R L Processo per la preparazione di derivati dell'acido sulfamoilbenzoico
WO2025257786A1 (en) * 2024-06-13 2025-12-18 Iama Therapeutics S.R.L. Benzoimidazole derivatives as nkcc1 inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493584A (en) * 1966-02-21 1970-02-03 Smithkline Corp 4-substituted amino-5-sulfamoylbenzoic acid derivatives and preparation
DE2412884A1 (de) * 1974-03-18 1975-10-16 Hoechst Ag Basisch substituierte benzolsulfonamide und verfahren zu ihrer herstellung
DE2442851A1 (de) * 1974-09-06 1976-03-18 Hoechst Ag Basisch substituierte 3-sulfamoylbenzoesaeurederivate und verfahren zu ihrer herstellung
DE2517183A1 (de) * 1975-04-18 1976-10-28 Hoechst Ag Basisch substituierte 5-sulfamoyl- anthranilsaeurederivate und verfahren zu ihrer herstellung
DE3101960A1 (de) * 1981-01-22 1982-09-02 Hoechst Ag, 6000 Frankfurt "basisch substituierte anthranilsaeuren, verfahren zu ihrer herstellung und ihre verwendung"
BE1012386A3 (fr) * 1999-01-15 2000-10-03 Univ Liege Derives de sulfonamides benzeniques et leurs utilisations.
WO2000058277A1 (en) 1999-03-31 2000-10-05 American Home Products Corporation Aryl sulfonic acids and derivatives as fsh antagonists
US6355633B1 (en) * 1999-03-31 2002-03-12 American Home Products Corporation Aryl sulfonic acids and derivatives as FSH antagonists
JP2002201172A (ja) * 2000-02-25 2002-07-16 Japan Tobacco Inc ベンズアミド誘導体及びその用途
WO2001062718A1 (en) * 2000-02-25 2001-08-30 Japan Tobacco, Inc. Benzamide derivative and use thereof
US7544676B2 (en) * 2005-11-10 2009-06-09 Adolor Corporation Sulfamoyl benzamides and methods of their use
CN102584649A (zh) 2006-06-22 2012-07-18 安那迪斯药品股份有限公司 吡咯并[1,2-b]哒嗪酮化合物
US7906555B2 (en) * 2006-10-26 2011-03-15 Arizona Board Of Regents On Behalf Of The University Of Arizona Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
CN102341380A (zh) * 2009-01-22 2012-02-01 神经病治疗药物股份有限公司 布美他尼、呋塞米、吡咯他尼、佐塞米和托拉塞米类似物、组合物和使用方法
JP2011231094A (ja) 2009-11-02 2011-11-17 Neurotherapeutics Pharma Inc ブメタニド、フロセミド、ピレタニド、アゾセミド、およびトルセミドのアナログ、組成物および使用方法

Similar Documents

Publication Publication Date Title
SI2961736T1 (en) Histone demethylase inhibitors
US7842681B2 (en) Treatment of myeoproliferative diseases
JP2005506308A5 (enExample)
JP2022502362A5 (enExample)
RU2006101541A (ru) Производные пиперазина и способ их применения
JP2004502670A5 (enExample)
CA2435067A1 (en) Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
RU2011110435A (ru) Пролекарства метилгидрофумарата, фармацетические композиции с ними и способы применения
RU2007119427A (ru) Соединения, являющиеся ингибиторами гликогенфосфорилазы, и фармацевтические композиции на их основе
JP2010522197A5 (enExample)
RU2013153130A (ru) Меченные радиоактивным изотопом аминокислоты для диагностической визуализации
RU2008135690A (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
AR059172A1 (es) Inhibidores triciclicos de la 5-lipoxigenasa
JP2006077019A5 (enExample)
JP2013503819A5 (enExample)
RU2010129541A (ru) Карбоксил- или гидроксилзамещенные производные бензимидазола
JP2024518555A5 (enExample)
JP2020511536A5 (enExample)
RU2008107733A (ru) Ингибиторы gsk-3
JP2016504992A5 (enExample)
JP2017509694A5 (enExample)
JP2018522916A5 (enExample)
JP2024532249A5 (enExample)
JP2025527291A5 (enExample)
RU2015130950A (ru) Агонисты рецептора окситоцина для лечения заболеваний центральной нервной системы